JPWO2024172057A1 - - Google Patents
Info
- Publication number
- JPWO2024172057A1 JPWO2024172057A1 JP2025501166A JP2025501166A JPWO2024172057A1 JP WO2024172057 A1 JPWO2024172057 A1 JP WO2024172057A1 JP 2025501166 A JP2025501166 A JP 2025501166A JP 2025501166 A JP2025501166 A JP 2025501166A JP WO2024172057 A1 JPWO2024172057 A1 JP WO2024172057A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
- C12N2310/141—MicroRNAs, miRNAs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023021890 | 2023-02-15 | ||
| PCT/JP2024/004958 WO2024172057A1 (ja) | 2023-02-15 | 2024-02-14 | 人工ｍｉＲＮＡ構築物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024172057A1 true JPWO2024172057A1 (https=) | 2024-08-22 |
Family
ID=92420145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025501166A Pending JPWO2024172057A1 (https=) | 2023-02-15 | 2024-02-14 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4667571A1 (https=) |
| JP (1) | JPWO2024172057A1 (https=) |
| AU (1) | AU2024221034A1 (https=) |
| WO (1) | WO2024172057A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008034123A2 (en) * | 2006-09-15 | 2008-03-20 | Enzon Pharmaceuticals, Inc. | Polymeric conjugates containing positively-charged moieties |
| JP2008206482A (ja) * | 2007-02-27 | 2008-09-11 | Hiroshima Univ | 癌の浸潤を指標とした診断マーカーおよび癌治療遺伝子 |
| GB0723246D0 (en) * | 2007-07-03 | 2008-01-09 | Barton Michelle | p53 modulator |
| JP2011093892A (ja) * | 2009-09-30 | 2011-05-12 | Japan Health Science Foundation | がん抑制的マイクロｒｎａを含む腫瘍増殖抑制剤 |
| EP2842546A4 (en) * | 2012-04-27 | 2015-12-30 | Univ Tokyo | PHARMACEUTICAL COMPOSITION WITH UNIT STRUCTURE FOR NUCLEIC ACID RELIEF |
| JP2015089874A (ja) * | 2013-11-05 | 2015-05-11 | 国立大学法人大阪大学 | ｍｉＲ−３４０を用いた大腸癌の治療剤 |
| CN109055522A (zh) * | 2018-07-03 | 2018-12-21 | 吉林大学 | C4orf38在制备用于检测或治疗神经性疼痛的产品中的应用 |
| AU2019390097A1 (en) * | 2018-11-30 | 2021-07-15 | Kyowa Kirin Co., Ltd. | Nucleic acid conjugate |
| WO2021159008A2 (en) * | 2020-02-07 | 2021-08-12 | Maze Therapeutics, Inc. | Compositions and methods for treating neurodegenerative diseases |
| WO2021239825A1 (en) * | 2020-05-27 | 2021-12-02 | Silence Therapeutics Gmbh | Nucleic acids for inhibiting expression of cnnm4 in a cell |
| CN113717971B (zh) * | 2021-08-10 | 2025-03-28 | 南通大学 | PGK1靶向siRNA干扰库及其应用 |
| EP4480494A4 (en) * | 2022-02-16 | 2026-03-11 | Univ Nat Corp Tokyo Medical & Dental | COMPOSITION INTENDED FOR USE IN THE TREATMENT OF CANCER, INFLAMMATORY DISEASES OR OBESITY, AND ITS USE |
-
2024
- 2024-02-14 JP JP2025501166A patent/JPWO2024172057A1/ja active Pending
- 2024-02-14 EP EP24756898.3A patent/EP4667571A1/en active Pending
- 2024-02-14 AU AU2024221034A patent/AU2024221034A1/en active Pending
- 2024-02-14 WO PCT/JP2024/004958 patent/WO2024172057A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4667571A1 (en) | 2025-12-24 |
| WO2024172057A1 (ja) | 2024-08-22 |
| AU2024221034A1 (en) | 2025-10-02 |